Date: 2014-10-28 02:27:30

Respiratory therapy

Monoclonal antibodies

Omalizumab

Asthma

Organochlorides

Immunology

Allergy

Cromoglicic acid

Montelukast

Pulmonology

Medicine

Chemistry

WATAG Advisory Note Approval for formulary listing of omalizumab (Xolair ®) WATAG advises that omalizumab is hereby approved for listing and hospital use in a highly targeted population of adult or adolescent patients w

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 102,94 KB